1. Home
  2. ATEN vs NVAX Comparison

ATEN vs NVAX Comparison

Compare ATEN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATEN
  • NVAX
  • Stock Information
  • Founded
  • ATEN 2004
  • NVAX 1987
  • Country
  • ATEN United States
  • NVAX United States
  • Employees
  • ATEN N/A
  • NVAX N/A
  • Industry
  • ATEN EDP Services
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATEN Technology
  • NVAX Health Care
  • Exchange
  • ATEN Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • ATEN 1.4B
  • NVAX 1.3B
  • IPO Year
  • ATEN 2014
  • NVAX 1995
  • Fundamental
  • Price
  • ATEN $17.98
  • NVAX $6.73
  • Analyst Decision
  • ATEN Strong Buy
  • NVAX Buy
  • Analyst Count
  • ATEN 3
  • NVAX 6
  • Target Price
  • ATEN $21.33
  • NVAX $15.33
  • AVG Volume (30 Days)
  • ATEN 841.5K
  • NVAX 5.1M
  • Earning Date
  • ATEN 08-05-2025
  • NVAX 08-06-2025
  • Dividend Yield
  • ATEN 1.32%
  • NVAX N/A
  • EPS Growth
  • ATEN 9.85
  • NVAX N/A
  • EPS
  • ATEN 0.67
  • NVAX 2.97
  • Revenue
  • ATEN $267,158,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • ATEN $9.54
  • NVAX $52.02
  • Revenue Next Year
  • ATEN $7.43
  • NVAX N/A
  • P/E Ratio
  • ATEN $27.14
  • NVAX $2.27
  • Revenue Growth
  • ATEN 4.90
  • NVAX 25.92
  • 52 Week Low
  • ATEN $12.27
  • NVAX $5.01
  • 52 Week High
  • ATEN $21.90
  • NVAX $15.22
  • Technical
  • Relative Strength Index (RSI)
  • ATEN 45.37
  • NVAX 45.60
  • Support Level
  • ATEN $17.67
  • NVAX $6.36
  • Resistance Level
  • ATEN $19.19
  • NVAX $6.81
  • Average True Range (ATR)
  • ATEN 0.38
  • NVAX 0.33
  • MACD
  • ATEN -0.10
  • NVAX -0.07
  • Stochastic Oscillator
  • ATEN 34.27
  • NVAX 19.05

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: